398 related articles for article (PubMed ID: 16928817)
1. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of radiation-induced DNA repair and prosurvival pathways contributes to vorinostat-mediated radiosensitization of pancreatic cancer cells.
Deorukhkar A; Shentu S; Park HC; Diagaradjane P; Puduvalli V; Aggarwal B; Guha S; Krishnan S
Pancreas; 2010 Nov; 39(8):1277-83. PubMed ID: 20531243
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair.
Lee JH; Choy ML; Ngo L; Foster SS; Marks PA
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14639-44. PubMed ID: 20679231
[TBL] [Abstract][Full Text] [Related]
5. Modulation of radiation response by histone deacetylase inhibition.
Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
[TBL] [Abstract][Full Text] [Related]
6. Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms.
Mueller S; Yang X; Sottero TL; Gragg A; Prasad G; Polley MY; Weiss WA; Matthay KK; Davidoff AM; DuBois SG; Haas-Kogan DA
Cancer Lett; 2011 Jul; 306(2):223-9. PubMed ID: 21497989
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation.
Cuneo KC; Fu A; Osusky K; Huamani J; Hallahan DE; Geng L
Anticancer Drugs; 2007 Aug; 18(7):793-800. PubMed ID: 17581301
[TBL] [Abstract][Full Text] [Related]
8. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells.
Zhang F; Zhang T; Teng ZH; Zhang R; Wang JB; Mei QB
Cancer Biol Ther; 2009 May; 8(9):823-31. PubMed ID: 19270532
[TBL] [Abstract][Full Text] [Related]
9. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
[TBL] [Abstract][Full Text] [Related]
10. Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts.
Baschnagel A; Russo A; Burgan WE; Carter D; Beam K; Palmieri D; Steeg PS; Tofilon P; Camphausen K
Mol Cancer Ther; 2009 Jun; 8(6):1589-95. PubMed ID: 19509253
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors enhance phosphorylation of histone H2AX after ionizing radiation.
Zhang Y; Adachi M; Zou H; Hareyama M; Imai K; Shinomura Y
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):859-66. PubMed ID: 16751067
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors.
Zhang Y; Jung M; Dritschilo A; Jung M
Radiat Res; 2004 Jun; 161(6):667-74. PubMed ID: 15161353
[TBL] [Abstract][Full Text] [Related]
13. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
Raju U; Nakata E; Mason KA; Ang KK; Milas L
Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
Richon VM; Sandhoff TW; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
[TBL] [Abstract][Full Text] [Related]
15. Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor.
Yaneva M; Li H; Marple T; Hasty P
Nucleic Acids Res; 2005; 33(16):5320-30. PubMed ID: 16177181
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition.
Blattmann C; Oertel S; Ehemann V; Thiemann M; Huber PE; Bischof M; Witt O; Deubzer HE; Kulozik AE; Debus J; Weber KJ
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):237-45. PubMed ID: 20646843
[TBL] [Abstract][Full Text] [Related]
17. Alterations in histone acetylation following exposure to
Tian XL; Lu X; Feng JB; Cai TJ; Li S; Tian M; Liu QJ
Radiat Environ Biophys; 2018 Aug; 57(3):215-222. PubMed ID: 29774413
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of suberoylanilide hydroxamic acid (SAHA) on chemoradiation for human cervical cancer cells and its mechanism.
Xing J; Wang H; Xu S; Han P; Xin M; Zhou JL
Eur J Gynaecol Oncol; 2015; 36(2):117-22. PubMed ID: 26050346
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization of glioblastoma cells using a histone deacetylase inhibitor (SAHA) comparing carbon ions with X-rays.
Barazzuol L; Jeynes JC; Merchant MJ; Wéra AC; Barry MA; Kirkby KJ; Suzuki M
Int J Radiat Biol; 2015 Jan; 91(1):90-8. PubMed ID: 25040548
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.
Chen CS; Wang YC; Yang HC; Huang PH; Kulp SK; Yang CC; Lu YS; Matsuyama S; Chen CY; Chen CS
Cancer Res; 2007 Jun; 67(11):5318-27. PubMed ID: 17545612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]